Close combat soldiers must meet higher minimum standards. The new National Defense Authorization Act will require soldiers in close combat forces to meet higher minimum fitness standards for…
Read MoreHealth
Labor Department Awards Funding to Ohio for Employment and Training
The disaster relief is to support communities impacted by opioid use, addiction, and overdose. The U.S. Department of Labor announced the third incremental award, of over $2.8 million,…
Read More
FDA Approves Gene Therapies for Sickle Cell Disease
Two cell-based gene therapies will address the debilitating hereditary blood disorder. The U.S. Food and Drug Administration (FDA) has granted approval of two groundbreaking cell-based gene therapies, Casgevy…
Read More
FTC Sues to Block Acquisition of Exclusive Drug License
The deal would give the French company a pharmaceutical monopoly over Pompe Disease therapy. The Federal Trade Commission (FTC) has taken action to prevent Sanofi from acquiring an…
Read More
VA has Screened 5 Million Veterans for Toxic Exposure
In the year of screenings, most exposure due to burn pits in Iraq or Agent Orange in Vietnam. The Department of Veterans Affairs (VA) has announced that they…
Read More
Military Officials Testify About Low Recruitment Before Senate Committee
Army general calls 2023 “one of the toughest recruiting landscapes” he’s seen in his career. The U.S. military’s four recruiting chiefs testified before the Senate Armed Services Committee…
Read More
VA Postpones Ambulance Service Reimbursement Rule
The changes are intended to lower the cost of air ambulance services by establishing contracts. Veterans Affairs (VA) officials have decided to delay a rule change regarding ambulance…
Read More
FDA Issues Alert on Safety Concerns with Certain CPAP Machines
Reports of thermal issues with Philips DreamStation 2 CPAP Machines prompt discussions with the company. The U.S. Food and Drug Administration (FDA) has alerted patients and healthcare providers…
Read More
Senate Health Committee Considers Reauthorizing Opioid Treatment Legislation
The 2018 SUPPORT Act would be renewed after missing a September deadline. The Senate Health Committee has scheduled a meeting to consider the reauthorization of the SUPPORT Act,…
Read More
FDA Approves Treatment for Rare Tumors
Though noncancerous, the tumors can decrease quality of life. The U.S. Food and Drug Administration (FDA) recently approved Ogsiveo (nirogacestat) tablets as the first-ever treatment for desmoid tumors—a…
Read More